S-nitrosoglutathione increases cystic fibrosis transmembrane regulator maturation

Biochemical and Biophysical Research Communications

Volumn 284, Issue 1, 2001, Pages 65-70

  Zaman, Khalequz ^a   McPherson, Marianne ^a   Vaughan, John ^a   Hunt, John ^a   Mendes, Filipa ^b   Gaston, Benjamin ^a   Palmer, Lisa A ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

Author keywords

Cystic fibrosis; Cystic fibrosis transmembrane conductance regulator; S nitrosoglutathione; S nitrosylation

Indexed keywords

ACIVICIN; CYCLOHEXIMIDE; DITHIOTHREITOL; GAMMA GLUTAMYLTRANSFERASE; MUTANT PROTEIN; PROTEASOME INHIBITOR; S NITROSOGLUTATHIONE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ARTICLE; CELL STRAIN; CONCENTRATION RESPONSE; CYSTIC FIBROSIS; DOSE TIME EFFECT RELATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; REGULATORY MECHANISM;

EID: 0034804969     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2001.4935     Document Type: Article

References (28)

1. Defects in processing and trafficking of the cystic fibrosis transmembrane conductance regulator
2. Cotranslational ubiquitination of cystic fibrosis transmembrane conductance regulator in vitro
3. Intracellular turnover of cystic fibrosis transmembrane conductance regulator
4. The Delta F508 mutation decreases the stability of cystic fibrosis transmembrane conductance regulator in the plasma membrane. Determination of functional half-lives on transfected cells
5. Biosynthesis and degradation of CFTR
6. Chloride conductance expressed by ΔF508 and other mutant CFTRs in Xenopus oocytes
7. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive
8. Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation
9. Chemical chaperones correct the mutant phenotype of the delta F508 cystic fibrosis transmembrane conductance regulator protein
10. Sodium 4-phenylbutyrate downregulates Hsc70: Implications for intracellular trafficking of deltaF508-CFTR
11. Pharmacogenomics of the cystic fibrosis transmembrane conductance regulator (CFTR) and the cystic fibrosis drug CPX using genome microarray analysis
12. Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways
13. S-nitrosoglutathione in rat cerebellum: Identification and quantification by liquid chromatography-mass spectrometry
14. Regulation of ciliary beat frequency by the nitric oxide-cyclic guanosine monophosphate signaling pathway in rat airway epithelial cells
15. Nitric oxide inhibits lung sodium transport through a cGMP-mediated inhibition of epithelial cation channels
16. Nitric oxide activate chloride currents in human lung epithelial cells
17. Cysteine nitrosylation inactivates the HIV-1 protease
18. An antiviral mechanism of nitric oxide: Inhibition of a viral protease
19. Decreased levels of nitrosothiols in the lower airways of patients with cystic fibrosis and normal pulmonary function
20. A cystic fibrosis pancreatic adenocarcinoma cell line
21. Correction of the cystic fibrosis defect in vitro by retrovirus mediated gene transfer
22. Phosphorylation-regulated Cl- channel in CHO cells stably expressing the cystic fibrosis gene
23. S-nitrosoglutathione as a substrate for gamma glutamyl transpeptidase
24. Normoxic stabilization of hypoxia-inducible factor-1 expression and activity: Redox-dependent effect of nitrogen oxides
25. The mechanism underlying cystic fibrosis transmembrane conductance regulator transport from the endoplasmic reticulum to the proteasome includes Sec61β and a cytosolic, deglycosylated intermediary
26. Homocysteine antagonism of nitric oxide-related cytostasis in Salmonella typhimurium
27. Aerosolized S-nitrosoglutathione improves oxygenation in cystic fibrosis